Nanjing King-friend Biochemical Pharmaceutical Co.
Latest round
- Series A
Last raised
- May 2011
Total raised
- $43M
Investors
- 3
About Nanjing King-friend Biochemical Pharmaceutical Co.
, Ltd specializes in biopharmaceuticals.21 each., Ltd specializes in the development and manufacturing of pharmaceutical products, particularly in biopharmaceuticals and health supplements. Their core offerings include biologics such as monoclonal antibodies and recombinant proteins, targeting diseases like cancer and autoimmune disorders.7. Revenue is generated through direct sales to healthcare providers and research institutions, utilizing a B2B model for consistent product supply., Ltd plans to expand its product line with new biopharmaceuticals to be launched by 2024, targeting specific therapeutic areas. They aim to penetrate new markets in Southeast Asia and Latin America within the next three years.8 million will support these initiatives, facilitating research and development for upcoming products and enhancing market entry strategies.
Who invested in Nanjing King-friend Biochemical Pharmaceutical Co.
3 investors across 2 rounds
See all investors in Nanjing King-friend Biochemical Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nanjing King-friend Biochemical Pharmaceutical Co.
Who invested in Nanjing King-friend Biochemical Pharmaceutical Co.?
Nanjing King-friend Biochemical Pharmaceutical Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing King-friend Biochemical Pharmaceutical Co. raised?
Nanjing King-friend Biochemical Pharmaceutical Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nanjing King-friend Biochemical Pharmaceutical Co. last raise money?
Nanjing King-friend Biochemical Pharmaceutical Co.'s most recent round on record is a Series A, in May 2011.
What does Nanjing King-friend Biochemical Pharmaceutical Co. do?
, Ltd specializes in biopharmaceuticals.
Where is Nanjing King-friend Biochemical Pharmaceutical Co. headquartered?
Nanjing King-friend Biochemical Pharmaceutical Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing King-friend Biochemical Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Nanjing King-friend Biochemical Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Nanjing King-friend Biochemical Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.